

Our mission
We aim to achieve long-term survival for cancer patients by bridging the medical physics of ablative interventions and immuntherapy to enable individualized cancer care.
Goals
- To gain a fundamental understanding of the mode-of-action of ablative technologies focusing on immunological and Tumor MicroEnvironment (TME) effects.
- To develop innovative immune modulatory therapies for in vivo programming of (innate) immune cells and fibroblasts for combination therapies.
- To develop (early) clinical feasibility and translational studies, guided by early health technology assessments to ensure responsible research and innovation.
- To train next generation professionals to bridge the medical physics of ablative interventions and immunotherapy.